|
麗珠醫藥集團股份有限公司- H股, 01513.HK - 財務比率 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
變現能力分析 |
流動比率(倍) |
2.3 |
2.12 |
2.4 |
2.43 |
2.32 |
2.57 |
1.8 |
1.13 |
1.19 |
1.28 |
1.25 |
速動比率(倍) |
2.02 |
1.88 |
2.16 |
2.21 |
2.11 |
2.32 |
1.47 |
0.82 |
0.87 |
1.0 |
1.02 |
償債能力分析 |
長期債項/股東權益(%) |
14.31 |
4.94 |
3.06 |
0.0 |
0.01 |
0.01 |
0.01 |
0.02 |
12.62 |
16.44 |
0.02 |
總債項/股東權益(%) |
26.08 |
20.72 |
15.87 |
12.19 |
14.09 |
0.01 |
0.01 |
5.77 |
30.92 |
31.14 |
17.85 |
總債項/資本運用(%) |
20.72 |
17.44 |
13.24 |
10.73 |
12.44 |
0.01 |
0.01 |
5.09 |
24.66 |
24.58 |
16.48 |
投資回報分析 |
股東權益回報率(%) |
13.76 |
13.66 |
14.16 |
11.67 |
10.16 |
41.11 |
12.06 |
14.33 |
13.96 |
14.58 |
14.68 |
資本運用回報率(%) |
10.93 |
11.5 |
11.82 |
10.27 |
8.97 |
38.55 |
10.87 |
12.65 |
11.14 |
11.51 |
13.56 |
總資產回報率(%) |
7.68 |
7.94 |
8.33 |
7.25 |
6.21 |
27.86 |
7.45 |
7.71 |
7.07 |
7.42 |
7.84 |
盈利能力分析 |
經營利潤率(%) |
18.61 |
18.79 |
23.77 |
18.43 |
14.38 |
66.32 |
11.52 |
10.46 |
10.54 |
12.79 |
13.15 |
稅前利潤率(%) |
18.45 |
18.62 |
23.66 |
18.41 |
15.99 |
67.11 |
13.14 |
12.2 |
11.76 |
13.62 |
14.21 |
邊際利潤率(%) |
15.12 |
14.72 |
16.3 |
13.88 |
12.21 |
51.91 |
10.25 |
9.4 |
9.31 |
10.56 |
11.2 |
營運能力分析 |
存貨周轉率(倍) |
6.17 |
7.25 |
7.07 |
8.03 |
7.93 |
7.74 |
6.96 |
6.73 |
6.54 |
7.2 |
7.22 |
投資收益分析 |
派息比率(%) |
78.43 |
68.42 |
68.31 |
82.73 |
79.47 |
24.72 |
32.89 |
30.86 |
5.75 |
30.3 |
0.0 |
相關統計 |
財政年度周最高價 |
31.6 |
42.0 |
42.6 |
24.9 |
53.186 |
65.0 |
50.95 |
53.21 |
62.5 |
0.0 |
0.0 |
財政年度周最低價 |
19.06 |
24.6 |
22.2 |
14.373 |
21.25 |
32.099 |
31.1 |
27.0 |
35.25 |
0.0 |
0.0 |
財政年度最高市盈率(倍) |
13.73 |
18.05 |
19.53 |
16.03 |
30.93 |
6.7 |
30.16 |
27.93 |
28.78 |
0.0 |
0.0 |
財政年度最低市盈率(倍) |
8.28 |
10.57 |
10.18 |
9.25 |
12.36 |
3.31 |
18.41 |
14.17 |
16.23 |
0.0 |
0.0 |
財政年度最高週息率(%) |
9.47 |
6.47 |
6.71 |
8.94 |
6.43 |
7.47 |
1.79 |
2.18 |
0.35 |
0.0 |
0.0 |
財政年度最低週息率(%) |
5.71 |
3.79 |
3.5 |
5.16 |
2.57 |
3.69 |
1.09 |
1.11 |
0.2 |
0.0 |
0.0 |
|
|